Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
356.12%
Change (1 year)
Categories
Market capitalization of Corbus Pharmaceuticals (CRBP)
Market cap: $0.40 Billion
As of May 2024 Corbus Pharmaceuticals has a market cap of $0.40 Billion. This makes Corbus Pharmaceuticals the world's 6230th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Corbus Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.40 B | 1424.62% |
| 2023 | $26.71 M | 93.01% |
| 2022 | $13.84 M | -82.05% |
| 2021 | $77.1 M | -26.6% |
| 2020 | $0.10 B | -70.25% |
| 2019 | $0.35 B | 5.62% |
| 2018 | $0.33 B | -15.26% |
| 2017 | $0.39 B | 5.07% |
| 2016 | $0.37 B | 505.17% |
| 2015 | $62.04 M | -19.99% |
| 2014 | $77.55 M |
End of Day market cap according to different sources
On May 3rd, 2024 the market cap of Corbus Pharmaceuticals was reported to be:
$0.40 Billion
$0.40 Billion
$0.40 Billion
$0.40 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $8.48 B | 1,983.47% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.28 B | -30.28% | 🇺🇸 USA |
 Epizyme EPZM | $0.24 B | -39.24% | 🇺🇸 USA |
 Advaxis ADXS | $23.63 M | -94.20% | 🇺🇸 USA |